Applications of 24-hour noninvasive ambulatory blood pressure monitoring

Journal of the Formosan Medical Association

Volumn 105, Issue 12, 2006, Pages 955-963

  Tseng, Yung Zu ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

ABPM; Circadian rhythm; Dipping load index; Target organ damage

Indexed keywords

ANTIHYPERTENSIVE AGENT; LONG ACTING DRUG;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT TOOL; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY MONITORING; GENETIC VARIABILITY; GRAFT RECIPIENT; HEALTH INSURANCE; HEART MUSCLE ISCHEMIA; HEART RATE; HEREDITY; HOLTER MONITORING; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY VASCULAR RESISTANCE; MONITOR; NON INVASIVE MEASUREMENT; ORGAN TRANSPLANTATION; OXYGEN CONSUMPTION; PATHOGENESIS; PATIENT CARE; PROGNOSIS; PSYCHOLOGICAL ASPECT; REIMBURSEMENT; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SPHYGMOMANOMETER; ST SEGMENT DEPRESSION; WHITE COAT HYPERTENSION;

EID: 33846291386     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60279-5     Document Type: Review

References (100)

1. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988;259:225-8.
2. White WB, Schulman P, McCabe EJ, et al. Average daily blood pressure not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261:873-7.
3. Staessen JA, Celis H, DenHond E, et al. Comparison of conventional and automated blood pressure measurements: interim analysis of the THOP trial. Blood Press Monit 2002;7:61-2.
4. Drayer JIM, Weber MA, DeYoung JL, et al. Long-term BP monitoring in the evaluation of antihypertensive therapy. Arch Intern Med 1983;143:898-901.
5. Sheps SG, Clement DL, Pickering TG, et al. Ambulatory blood pressure monitoring. Hypertensive Diseases Committee, American College of Cardiology. J Am Coll Cardiol 1994;23:1511-3.
6. Pickering TG. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996;9:1-11.
7. Zanchetti A. The role of ambulatory blood pressure monitoring in clinical practice. Am J Hypertens 1997;10: 1069-80.
8. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
9. Staessen JA, Beilin L, Parati G, et al. Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit 1999;4:319-31.
10. O'Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000;320:1128-34.
11. O'Brien E, Petrie J, Littler WA, et al. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11:677-9.
12. Pickering TG, Harshfield GA, Kleinert HD, et al. Blood pressure during normal daily activities, sleep, and exercise: comparison of values in normal and hypertensive subjects. JAMA 1982;247:992-6.
13. Messerli FH, Glade LB, Ventura HO, et al. Diurnal variations of cardiac rhythm, arterial pressure, and urinary catecholamines in borderline and established essential hypertension. Am Heart J 1982;104:109-14.
14. Chiang FT, Tseng CD, Hsu KL, et al. Circadian variations of atrial natriuretic peptide in normal people and its relationship to arterial blood pressure, plasma renin activity and aldosterone level. Int J Cardiol 1994;46:229-33.
15. Kennedy HL, Horan MJ, Sprague MK, et al. Ambulatory blood pressure in healthy normotensive males. Am Heart J 1983;106:717-22.
16. Weber MA, Drayer JIM, Nakamura DK, et al. The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol 1984;54:115-9.
17. Lin LJ, Tseng YZ, Chiang FT, et al. Ambulatory blood pressure in normal Chinese. J Formos Med Assoc 1990;89:90-6.
18. Tseng YZ, Tseng CD, Chiang FT, et al. The normalcy of blood pressure in well-controlled hypertensive patients. Am J Noninvas Cardiol 1992;6:95-8.
19. Drayer JIM, Weber MA, DeYoung JL, et al. Circadian blood pressure patterns in ambulatory hypertensive patients. Am J Med 1982;73:493-9.
20. Hany S, Baumgart P, Frielingsdorf J, et al. Circadian blood variability in secondary and essential hypertension. J Hypertens 1987;5(Suppl 5):S487-9.
21. Imai Y, Abe K, Sasaki S, et al. Alternated circadian blood pressure rhythm in patients with Cushing's syndrome. Hypertension 1988;12:11-9.
22. Kobrin I, Oigman W, Kumar A, et al. Diurnal variation of blood pressure in elderly patients with essential hypertension. J Am Geriatr Soc 1984;32:896-9.
23. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood pressure. Lancet 1978;1:795-7.
24. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983;53:96-104.
25. Sokolow M, Perloff D, Cowan R. Contribution of ambulatory blood pressure to the assessment of patients with mild to moderate elevation of office blood pressure. Cardiovasc Rev Rep 1980;1:295-303.
26. Waeber B, Jacot Des Combes B, Porchet M, et al. Ambulatory blood pressure recording to identify hypertensive patients who truly need therapy. J Chronic Dis 1984; 37:55-7.
27. Littler WA, Honour AJ, Sleight P. Direct arterial pressure, pulse rate and electrocardiogram during micturition and defecation in unrestricted man. Am Heart J 1974;88: 205-10.
28. Rowlands DB, Stallard TJ, Watson RD, et al. The influence of physical activity on arterial pressure during ambulatory recordings in man. Clin Sci 1980;58:115-7.
29. Uen S, Vetter H, Mengden T. Simultaneous recording of blood pressure and ST-segment with combined, triggered ambulatory 24-h devices. Blood Press Monit 2003;8:41-4.
30. Uen S, Baulmann J, Düsing R, et al. ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. J Hypertens 2003;21:977-83.
31. Sowers JR, Stern N, Nyby MD, et al. Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension. Cardiovasc Res 1982;16:317-23.
32. Jefferies CA, Hofman PL, Wong W, et al. Increased nocturnal blood pressure in healthy prepubertal twins. J Hypertens 2003;21:1319-24.
33. Jedrusik P, Januszewicz A, Busjahn A, et al. Genetic influence on blood pressure and lipid parameters in a sample of Polish twins. Blood Press 2003;12:7-11.
34. Lanzani C, Citterio L, Jankaricova M, et al. Role of the adducin family genes in human essential hypertension. J Hypertens 2005;23:543-9.
35. Ramunni A, Saracino A, Esposito T, et al. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease. Hypertens Res 2004;27:221-5.
36. Tonbul Z, Altintepe L, Sozlu C, et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003;23:46-52.
37. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792-8.
38. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987;5:93-8.
39. Pickering TG, Devereux RB. Ambulatory monitoring of blood pressure as a predictor of cardiovascular risk. Am Heart J 1987;114:925-8.
40. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure monitoring in treated hypertensive patients. J Hypertens 1991;9(Suppl 1):S33-40.
41. Mann S, Millar-Craig MW, Raftery EB. Superiority of 24-hour measurement of blood pressure over clinic values in determining prognosis in hypertension. Clin Exp Hypertens - Part A, Theory & Pract 1985; 7:279-81.
42. Tseng YZ, Tseng CD, Lo HM, et al. Characteristic abnormal findings of ambulatory blood pressure indicative of hypertensive target organ complications. Eur Heart J 1994; 15:1037-43.
43. Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.
44. Rahman M, Griffin V, Heyka R, et al. Diurnal variation of blood pressure: reproducibility and association with left ventricular hypertrophy in hemodialysis patients. Blood Press Monit 2005;10:25-32.
45. Cicconetti P, Morelli S, Ottaviani L, et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am J Hypertens 2003;16:900-5.
46. Cuspidi C, Michev I, Meani S, et al. Left ventricular hypertrophy in treated hypertensive patients with good blood pressure control outside the clinic, but poor clinic blood pressure control. J Hypertens 2003;21:1575-81.
47. Redon J, Liao Y, Lozano JV, et al. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994;12:947-53.
48. Timio M, Venanzi S, Lolli S, et al. Night-time blood pressure and progression of renal insufficiency. High Blood Press Cardiovasc Prev 1994;3:39-44.
49. Liu M, Takahashi H, Morita Y, et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003;18:563-9.
50. Lengyel Z, Rosivall L, Nemeth C, et al. Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients. Diabetes Res Clin Pract 2003;62: 159-67.
51. O'Sullivan C, Duggan J, Lyons S, et al. Hypertensive target-organ damage in the very elderly. Hypertension 2003;42: 130-5.
52. Cuspidi C, Meani S, Fusi V, et al. Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients. J Human Hypertens 2005; 19:471-7.
53. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875-8.
54. Gould BA, Mann S, Kieso H, et al. The 24-hour ambulatory blood pressure profile with verapamil. Circulation 1982; 65:22-8.
55. Staessen JA, Byttebier G, Buntinx F, et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial. JAMA 1997;278:1065-72.
56. Tseng CD, Tseng YZ, Lo HM, et al. Ambulatory blood pressure monitoring for evaluation of long-acting beta-blockers in Taiwan. J Formos Med Assoc 1996;95: 320-4.
57. Smith DHG, Neutel JM, Lacourcière Y, et al. Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J Hypertens 2003;21:1291-8.
58. Smith DHG, Dubiel R, Jones M. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan and irbesartan. Am J Cardiovasc Drugs 2005;5:41-50.
59. Andreadis EA, Tsourous GI, Marakomichelakis GE, et al. High-dose monotherapy us. low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. J Human Hypertens 2005;19:491-6.
60. Ruilope LM, Heintz D, Brandao AA, et al. 24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study. Blood Press Monit 2005;10:85-91.
61. Floras JS, Jones JV, Johnston JA, et al. Arousal and the circadian rhythm of blood pressure. Clin Sci Mol Med 1978; 4(Suppl):395S-7S.
62. Richards AM, Nicholls MG, Espiner FA, et al. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens -Part A, Theory & Pract 1986;8:153-66.
63. Yasuda G, Hasegawa K, Kuji T, et al. Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Am J Hypertens 2004;17:14-20.
64. Guasti L, Simoni C, Mainardi LT, et al. Circadian blood pressure variability is associated with autonomic and baroreflex-mediated modulation of the sinoatrial node. Acta Cardiologica 2005;60:319-24.
65. Reeves RA, Shapiro AP, Thompson ME, et al. Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986;73:401-8.
66. Martínez-Rey C, Otero-Antón E, Tomé S, et al. Circadian variability of blood pressure in liver transplant recipients without antihypertensive therapy. Transplant Proc 2005;37: 1515-6.
67. Lin LJ, Tseng YZ, Chiang FT, et al. Altered circadian rhythm of blood pressure in patients with cerebral stroke. Am J Noninuas Cardiol 1992;6:62-5.
68. Wang TL, Chiang FT, Hsu KL, et al. Abnormal circadian blood pressure changes in patients with acute cerebrovascular disorders. J Formos Med Assoc 1997;96: 710-7.
69. Julius S, Mejia A, Jones K, et al. "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 1990;16:617-23.
70. Schrader J, Lüders S, Züchner C, et al. Practice us. ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): a randomised, prospective longterm study to evaluate the benefits of ABPM in patients on antihypertensive treatment. J Human Hypertens 2000; 14:435-40.
71. Sorof JM. White coat hypertension in children. Blood Press Monit 2000;5:197-202.
72. Brown MA, Mangos G, Davis G, et al. The natural history of white coat hypertension during pregnancy. BJOG 2005;112:601-6.
73. Gosse P, Promax H, Durandet P, et al. 'White coat' hypertension. No harm for the heart. Hypertension 1993;22: 766-70.
74. Hoegholm A, Kristensen KS, Bang LE, et al. Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993;6:282-6.
75. Björklund K, Lind L, Vessby B, et al. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period. A population-based study of elderly men. Circulation 2002;106:63-8.
76. Polónia JJ, Gama GM, Silva JA, et al. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives. Blood Press Monit 2005;10:57-64.
77. Tseng YZ, Chiang FT, Hsu KL, et al. Low frequency of target organ damage in Taiwanese with white coat hypertension. J Formos Med Assoc 2005;104:327-32.
78. Covic A, Segall L, Goldsmith DJA. Ambulatory blood pressure monitoring in renal transplantation: should ABPM be routinely performed in renal transplant patients? Transplantation 2003;76:1640-2.
79. Haydar AA, Covic A, Jayawardene S, et al. Insights from ambulatory blood pressure monitoring: diagnosis of hypertension and diurnal blood pressure in renal transplant recipients. Transplantation 2004;77:849-53.
80. Mitsnefes MM, Portman RJ. Ambulatory blood pressure monitoring in pediatric renal transplantations. Pediatr Transplant 2003;7:86-92.
81. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001;14:1263-9.
82. Muxfeldt ES, Bloch KV, Nogueira AR, et al. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003;8:181-5.
83. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107:1401-6.
84. Laurent S. Very low-dose combination of perindopril and indapamide: efficacy on blood pressure and target-organ damage. J Hypertens 2003;21(Suppl 3):S11-8.
85. Celentano A, Crivaro M, Perticone F, et al. Anti-hypertensive effect of manidipine: 24 hours monitoring evaluation and Doppler-echocardiographic remarks. Blood Press 1996;5(Suppl):29-35.
86. Mallion JM, Chamontin B, Asmar R, et al. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Am J Hypertens 2004;17:245-51.
87. Ohkubo T, Kiyuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005;46:508-15.
88. Haydar AA, Covic A, Agharazii M, et al. Systolic blood pressure diurnal variation is not a predictor of renal target organ damage in kidney transplant recipients. Am J Transplant 2004;4:244-7.
89. Varda NM, Gregorič A. Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers. Pediatr Nephrol 2005;20:798-802.
90. Wühl E, Hadtstein C, Mehls O, et al. Home, clinic and ambulatory blood pressure monitoring in children with chronic renal failure. Pediatr Res 2004;55:492-7.
91. Lama G, Tedesco MA, Graziano L, et al. Reflux nephropathy and hypertension: correlation with the progression of renal damage. Pediatr Nephrol 2003;18: 241-5.
92. Mallion JM, de Gandemaris R, Bagnet JP, et al. Acceptability and tolerance of ambulatory blood pressure measurement in the hypertensive patient. Blood Press Monit 1996;1:475-80.
93. O'Brien E, Murphy J, Tyndall A, et al. Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: the Allied Irish Bank Study. J Hypertens 1991;9:355-60.
94. Imai Y, Nagai K, Sakuma M, et al. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 1993;22:900-12.
95. Staessen JA, O'Brien E, Amery AK, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens 1994;12(Suppl 7):S1-12.
96. Mancia G, Sega R, Bravi C, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995;13:1377-90.
97. Ohkubo T, Imai Y, Tsuji I, et al. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama study. Hypertension 1998;32:255-9.
98. Moser M. Hypertension can be treated effectively without increasing the cost of care. J Human Hypertens 1996; 10(Suppl 2):S33-8.
99. Pierdomenico SD, Mezzetti A, Lapenna D, et al. "Whitecoat" hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 1995;16:692-7.
100. Krakoff LR. Cost-effectiveness of ambulatory blood pressure. A reanalysis. Hypertension 2006;47:29-34.